Abbott Laboratories
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $14.08B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.18B | 15.5% |
| Other Investing | $129.4M | 0.9% |
| Dividends Paid | $3.84B | 27.3% |
| Stock Repurchases | $1.30B | 9.2% |
| Net Change in Short-Term Borrowings | $100.0M | 0.7% |
| Other Financing | $173.0M | 1.2% |
| Working Capital | $5.52B | 39.2% |
| Other | $124.0M | 0.9% |
| Net Cash Flow | $720.0M | 5.1% |